author_facet Jafri, Mariam
Wake, Naomi C.
Ascher, David B.
Pires, Douglas E.V.
Gentle, Dean
Morris, Mark R.
Rattenberry, Eleanor
Simpson, Michael A.
Trembath, Richard C.
Weber, Astrid
Woodward, Emma R.
Donaldson, Alan
Blundell, Tom L.
Latif, Farida
Maher, Eamonn R.
Jafri, Mariam
Wake, Naomi C.
Ascher, David B.
Pires, Douglas E.V.
Gentle, Dean
Morris, Mark R.
Rattenberry, Eleanor
Simpson, Michael A.
Trembath, Richard C.
Weber, Astrid
Woodward, Emma R.
Donaldson, Alan
Blundell, Tom L.
Latif, Farida
Maher, Eamonn R.
author Jafri, Mariam
Wake, Naomi C.
Ascher, David B.
Pires, Douglas E.V.
Gentle, Dean
Morris, Mark R.
Rattenberry, Eleanor
Simpson, Michael A.
Trembath, Richard C.
Weber, Astrid
Woodward, Emma R.
Donaldson, Alan
Blundell, Tom L.
Latif, Farida
Maher, Eamonn R.
spellingShingle Jafri, Mariam
Wake, Naomi C.
Ascher, David B.
Pires, Douglas E.V.
Gentle, Dean
Morris, Mark R.
Rattenberry, Eleanor
Simpson, Michael A.
Trembath, Richard C.
Weber, Astrid
Woodward, Emma R.
Donaldson, Alan
Blundell, Tom L.
Latif, Farida
Maher, Eamonn R.
Cancer Discovery
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Oncology
author_sort jafri, mariam
spelling Jafri, Mariam Wake, Naomi C. Ascher, David B. Pires, Douglas E.V. Gentle, Dean Morris, Mark R. Rattenberry, Eleanor Simpson, Michael A. Trembath, Richard C. Weber, Astrid Woodward, Emma R. Donaldson, Alan Blundell, Tom L. Latif, Farida Maher, Eamonn R. 2159-8274 2159-8290 American Association for Cancer Research (AACR) Oncology http://dx.doi.org/10.1158/2159-8290.cd-14-1096 <jats:title>Abstract</jats:title> <jats:p>Familial renal cell carcinoma (RCC) is genetically heterogeneous and may be caused by mutations in multiple genes, including VHL, MET, SDHB, FH, FLCN, PTEN, and BAP1. However, most individuals with inherited RCC do not have a detectable germline mutation. To identify novel inherited RCC genes, we undertook exome resequencing studies in a familial RCC kindred and identified a CDKN2B nonsense mutation that segregated with familial RCC status. Targeted resequencing of CDKN2B in individuals (n = 82) with features of inherited RCC then revealed three candidate CDKN2B missense mutations (p.Pro40Thr, p.Ala23Glu, and p.Asp86Asn). In silico analysis of the three-dimensional structures indicated that each missense substitution was likely pathogenic through reduced stability of the mutant or reduced affinity for cyclin-dependent kinases 4 and 6, and in vitro studies demonstrated that each of the mutations impaired CDKN2B-induced suppression of proliferation in an RCC cell line. These findings identify germline CDKN2B mutations as a novel cause of familial RCC.</jats:p> <jats:p>Significance: Germline loss-of-function CDKN2B mutations were identified in a subset of patients with features of inherited RCC. Detection of germline CDKN2B mutations will have an impact on familial cancer screening and might prove to influence the management of disseminated disease. Cancer Discov; 5(7); 723–9. ©2015 AACR.</jats:p> <jats:p>This article is highlighted in the In This Issue feature, p. 681</jats:p> Germline Mutations in the <i>CDKN2B</i> Tumor Suppressor Gene Predispose to Renal Cell Carcinoma Cancer Discovery
doi_str_mv 10.1158/2159-8290.cd-14-1096
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8yMTU5LTgyOTAuY2QtMTQtMTA5Ng
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8yMTU5LTgyOTAuY2QtMTQtMTA5Ng
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint American Association for Cancer Research (AACR), 2015
imprint_str_mv American Association for Cancer Research (AACR), 2015
issn 2159-8274
2159-8290
issn_str_mv 2159-8274
2159-8290
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str jafri2015germlinemutationsinthecdkn2btumorsuppressorgenepredisposetorenalcellcarcinoma
publishDateSort 2015
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Discovery
source_id 49
title Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_unstemmed Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_full Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_fullStr Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_full_unstemmed Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_short Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_sort germline mutations in the <i>cdkn2b</i> tumor suppressor gene predispose to renal cell carcinoma
topic Oncology
url http://dx.doi.org/10.1158/2159-8290.cd-14-1096
publishDate 2015
physical 723-729
description <jats:title>Abstract</jats:title> <jats:p>Familial renal cell carcinoma (RCC) is genetically heterogeneous and may be caused by mutations in multiple genes, including VHL, MET, SDHB, FH, FLCN, PTEN, and BAP1. However, most individuals with inherited RCC do not have a detectable germline mutation. To identify novel inherited RCC genes, we undertook exome resequencing studies in a familial RCC kindred and identified a CDKN2B nonsense mutation that segregated with familial RCC status. Targeted resequencing of CDKN2B in individuals (n = 82) with features of inherited RCC then revealed three candidate CDKN2B missense mutations (p.Pro40Thr, p.Ala23Glu, and p.Asp86Asn). In silico analysis of the three-dimensional structures indicated that each missense substitution was likely pathogenic through reduced stability of the mutant or reduced affinity for cyclin-dependent kinases 4 and 6, and in vitro studies demonstrated that each of the mutations impaired CDKN2B-induced suppression of proliferation in an RCC cell line. These findings identify germline CDKN2B mutations as a novel cause of familial RCC.</jats:p> <jats:p>Significance: Germline loss-of-function CDKN2B mutations were identified in a subset of patients with features of inherited RCC. Detection of germline CDKN2B mutations will have an impact on familial cancer screening and might prove to influence the management of disseminated disease. Cancer Discov; 5(7); 723–9. ©2015 AACR.</jats:p> <jats:p>This article is highlighted in the In This Issue feature, p. 681</jats:p>
container_issue 7
container_start_page 723
container_title Cancer Discovery
container_volume 5
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344998958596100
geogr_code not assigned
last_indexed 2024-03-01T17:16:27.028Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Germline+Mutations+in+the+CDKN2B+Tumor+Suppressor+Gene+Predispose+to+Renal+Cell+Carcinoma&rft.date=2015-07-01&genre=article&issn=2159-8290&volume=5&issue=7&spage=723&epage=729&pages=723-729&jtitle=Cancer+Discovery&atitle=Germline+Mutations+in+the+%3Ci%3ECDKN2B%3C%2Fi%3E+Tumor+Suppressor+Gene+Predispose+to+Renal+Cell+Carcinoma&aulast=Maher&aufirst=Eamonn+R.&rft_id=info%3Adoi%2F10.1158%2F2159-8290.cd-14-1096&rft.language%5B0%5D=eng
SOLR
_version_ 1792344998958596100
author Jafri, Mariam, Wake, Naomi C., Ascher, David B., Pires, Douglas E.V., Gentle, Dean, Morris, Mark R., Rattenberry, Eleanor, Simpson, Michael A., Trembath, Richard C., Weber, Astrid, Woodward, Emma R., Donaldson, Alan, Blundell, Tom L., Latif, Farida, Maher, Eamonn R.
author_facet Jafri, Mariam, Wake, Naomi C., Ascher, David B., Pires, Douglas E.V., Gentle, Dean, Morris, Mark R., Rattenberry, Eleanor, Simpson, Michael A., Trembath, Richard C., Weber, Astrid, Woodward, Emma R., Donaldson, Alan, Blundell, Tom L., Latif, Farida, Maher, Eamonn R., Jafri, Mariam, Wake, Naomi C., Ascher, David B., Pires, Douglas E.V., Gentle, Dean, Morris, Mark R., Rattenberry, Eleanor, Simpson, Michael A., Trembath, Richard C., Weber, Astrid, Woodward, Emma R., Donaldson, Alan, Blundell, Tom L., Latif, Farida, Maher, Eamonn R.
author_sort jafri, mariam
container_issue 7
container_start_page 723
container_title Cancer Discovery
container_volume 5
description <jats:title>Abstract</jats:title> <jats:p>Familial renal cell carcinoma (RCC) is genetically heterogeneous and may be caused by mutations in multiple genes, including VHL, MET, SDHB, FH, FLCN, PTEN, and BAP1. However, most individuals with inherited RCC do not have a detectable germline mutation. To identify novel inherited RCC genes, we undertook exome resequencing studies in a familial RCC kindred and identified a CDKN2B nonsense mutation that segregated with familial RCC status. Targeted resequencing of CDKN2B in individuals (n = 82) with features of inherited RCC then revealed three candidate CDKN2B missense mutations (p.Pro40Thr, p.Ala23Glu, and p.Asp86Asn). In silico analysis of the three-dimensional structures indicated that each missense substitution was likely pathogenic through reduced stability of the mutant or reduced affinity for cyclin-dependent kinases 4 and 6, and in vitro studies demonstrated that each of the mutations impaired CDKN2B-induced suppression of proliferation in an RCC cell line. These findings identify germline CDKN2B mutations as a novel cause of familial RCC.</jats:p> <jats:p>Significance: Germline loss-of-function CDKN2B mutations were identified in a subset of patients with features of inherited RCC. Detection of germline CDKN2B mutations will have an impact on familial cancer screening and might prove to influence the management of disseminated disease. Cancer Discov; 5(7); 723–9. ©2015 AACR.</jats:p> <jats:p>This article is highlighted in the In This Issue feature, p. 681</jats:p>
doi_str_mv 10.1158/2159-8290.cd-14-1096
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8yMTU5LTgyOTAuY2QtMTQtMTA5Ng
imprint American Association for Cancer Research (AACR), 2015
imprint_str_mv American Association for Cancer Research (AACR), 2015
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 2159-8274, 2159-8290
issn_str_mv 2159-8274, 2159-8290
language English
last_indexed 2024-03-01T17:16:27.028Z
match_str jafri2015germlinemutationsinthecdkn2btumorsuppressorgenepredisposetorenalcellcarcinoma
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 723-729
publishDate 2015
publishDateSort 2015
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Discovery
source_id 49
spelling Jafri, Mariam Wake, Naomi C. Ascher, David B. Pires, Douglas E.V. Gentle, Dean Morris, Mark R. Rattenberry, Eleanor Simpson, Michael A. Trembath, Richard C. Weber, Astrid Woodward, Emma R. Donaldson, Alan Blundell, Tom L. Latif, Farida Maher, Eamonn R. 2159-8274 2159-8290 American Association for Cancer Research (AACR) Oncology http://dx.doi.org/10.1158/2159-8290.cd-14-1096 <jats:title>Abstract</jats:title> <jats:p>Familial renal cell carcinoma (RCC) is genetically heterogeneous and may be caused by mutations in multiple genes, including VHL, MET, SDHB, FH, FLCN, PTEN, and BAP1. However, most individuals with inherited RCC do not have a detectable germline mutation. To identify novel inherited RCC genes, we undertook exome resequencing studies in a familial RCC kindred and identified a CDKN2B nonsense mutation that segregated with familial RCC status. Targeted resequencing of CDKN2B in individuals (n = 82) with features of inherited RCC then revealed three candidate CDKN2B missense mutations (p.Pro40Thr, p.Ala23Glu, and p.Asp86Asn). In silico analysis of the three-dimensional structures indicated that each missense substitution was likely pathogenic through reduced stability of the mutant or reduced affinity for cyclin-dependent kinases 4 and 6, and in vitro studies demonstrated that each of the mutations impaired CDKN2B-induced suppression of proliferation in an RCC cell line. These findings identify germline CDKN2B mutations as a novel cause of familial RCC.</jats:p> <jats:p>Significance: Germline loss-of-function CDKN2B mutations were identified in a subset of patients with features of inherited RCC. Detection of germline CDKN2B mutations will have an impact on familial cancer screening and might prove to influence the management of disseminated disease. Cancer Discov; 5(7); 723–9. ©2015 AACR.</jats:p> <jats:p>This article is highlighted in the In This Issue feature, p. 681</jats:p> Germline Mutations in the <i>CDKN2B</i> Tumor Suppressor Gene Predispose to Renal Cell Carcinoma Cancer Discovery
spellingShingle Jafri, Mariam, Wake, Naomi C., Ascher, David B., Pires, Douglas E.V., Gentle, Dean, Morris, Mark R., Rattenberry, Eleanor, Simpson, Michael A., Trembath, Richard C., Weber, Astrid, Woodward, Emma R., Donaldson, Alan, Blundell, Tom L., Latif, Farida, Maher, Eamonn R., Cancer Discovery, Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma, Oncology
title Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_full Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_fullStr Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_full_unstemmed Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_short Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
title_sort germline mutations in the <i>cdkn2b</i> tumor suppressor gene predispose to renal cell carcinoma
title_unstemmed Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
topic Oncology
url http://dx.doi.org/10.1158/2159-8290.cd-14-1096